eCite Digital Repository

Geron's hFSC Trial for Spinal Cord Injury: The Risk of Therapeutic Misconception

Citation

Gilbert, F, Geron's hFSC Trial for Spinal Cord Injury: The Risk of Therapeutic Misconception, The Hastings Center Report: Bioethics Forum, The Hastings Centre, USA, April, 17th (2009) [Internal Newsletter]


Preview
PDF
Pending copyright assessment - Request a copy
330Kb
  

Abstract

In late January 2009, the Food and Drug Administration (FDA) in the United States approved Geronís first-in-human embryonic stem cell trial for spinal cord injury patients. At the time, media pundits noted that this decision coincided with the inauguration of President Barack Obama. Since then, President Obama has overturned the ban on federal funding for research involving the derivation of human embryonic stem cells (hESCs) Ė a ban introduced in August 2001 by President George W. Bush.

It is anticipated that President Obamaís decision will not only increase research in the U.S. to derive hESCs, but will also affect the flow of applications to the FDA for approval of clinical trials involving the transplantation of hESCs. Consequently, Geronís trial is precedent-setting not only in terms of the science, but also in terms of the ethics and the politics of hESC research. It most certainly will constitute a reference point for future hESC trials.

[Read more here]

Item Details

Item Type:Internal Newsletter
Keywords:embryonic stem cell, clinical trial, therapeutic misconception, spinal cord
Research Division:Philosophy and Religious Studies
Research Group:Applied Ethics
Research Field:Ethical Use of New Technology (e.g. Nanotechnology, Biotechnology)
Objective Division:Expanding Knowledge
Objective Group:Expanding Knowledge
Objective Field:Expanding Knowledge in Philosophy and Religious Studies
Author:Gilbert, F (Dr Frederic Gilbert)
ID Code:80093
Year Published:2009
Deposited By:Faculty of Arts
Deposited On:2012-10-22
Last Modified:2013-07-15
Downloads:0

Repository Staff Only: item control page